Početna stranicaBSX • NYSE
add
Boston Scientific Corp
100,96 $
Poslije radnog vremena:(0,00 %)0,00
100,96 $
Zatvoreno: 26. stu, 17:04:48 GMT -5 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
101,36 $
Dnevni raspon
100,90 $ - 101,69 $
Godišnji raspon
85,98 $ - 109,50 $
Tržišna kapitalizacija
144,77 mlr. USD
Prosječna količina
8,98 mil.
P/E omjer
54,02
Prinos dividende
-
Glavno tržište vrijednosnica
NYSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 5,06 mlr. | 20,34 % |
Operativni troškovi | 2,48 mlr. | 14,08 % |
Neto dohodak | 755,00 mil. | 60,98 % |
Neto profitabilnost | 14,91 | 33,84 % |
Zarada po dionici | 0,75 | 19,05 % |
EBITDA | 1,39 mlr. | 35,94 % |
Efektivna porezna stopa | 19,51 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 1,28 mlr. | −49,04 % |
Ukupna imovina | 42,71 mlr. | 12,16 % |
Ukupne obveze | 19,08 mlr. | 11,42 % |
Ukupni kapital | 23,63 mlr. | — |
Dionice u optjecaju | 1,48 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 6,42 | — |
Povrat imovine | 6,23 % | — |
Povrat kapitala | 7,46 % | — |
Tok novca
Neto promjena novca
| (USD) | ruj 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 755,00 mil. | 60,98 % |
Gotovina od poslovanja | 1,34 mlr. | 34,03 % |
Gotovina iz ulaganja | −502,00 mil. | 64,82 % |
Gotovina iz financiranja | −104,00 mil. | −1.585,71 % |
Neto promjena novca | 735,00 mil. | 277,97 % |
Slobodan tok novca | 724,88 mil. | 19,35 % |
Više
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
Glavni izvršni direktor
Osnovano
1979
Web-lokacija
Zaposlenici
53.000
